GlassScriptPhysician profile
Madeline Drake
NPI 1235870916
$6,465.36
in general payments reported to CMS, 2019-2025
16 companies · $1,361 in 2025
The $1,361 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $926 · 2023: $1,824 · 2024: $2,354 · 2025: $1,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,539.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,312.51 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $1,100.86 | 2023-2025 | Enroute Transcarotid Neuroprotection System, Ekosonic, Eluvia |
| Inari Medical, INC. | $952.21 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $691.76 | 2024 | Endurant Iis |
| Shockwave Medical, INC | $320.22 | 2025 | |
| Terumo Medical Corporation | $273.61 | 2023-2025 | Angio-Seal, Azur Cx Detachable, Glidesheath Slender |
| Angiodynamics, INC. | $233.71 | 2022-2025 | Alphavac |
| Bolton Medical INC | $222.62 | 2024-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Organogenesis INC. | $110.46 | 2025 | Puraply Wound Matrix |
| Ethicon US, LLC | $72.83 | 2024 | Evarrest, Prolene, Dermabond Prineo |
| Abiomed | $48.02 | 2025 | |
| Imperative Care, INC | $43.53 | 2025 | Symphony Catheter |
| Teleflex LLC | $22.93 | 2025 | Quikclot |
| Convatec INC. | $21.03 | 2022 | |
| Merck Sharp & Dohme LLC | $20.62 | 2024 | Recarbrio, Zerbaxa, Dificid |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $18.44 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Drake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.